Brevan Howard Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-34,578
Closed -$275K 1336
2024
Q1
$275K Buy
+34,578
New +$275K ﹤0.01% 642